低分子原薬市場：タイプ別、製品別、用途別-2025-2030年の世界予測

低分子原薬市場は、2023年に1,843億2,000万米ドルと評価され、2024年には1,973億5,000万米ドルに達すると予測され、CAGR 7.26%で成長し、2030年には3,011億9,000万米ドルに達すると予測されています。

低分子原薬市場の対象範囲には、医薬品製剤に不可欠な医薬品成分が幅広く含まれています。これらの分子は、病気の診断、治療、予防を助ける小さな有機化合物です。低分子原薬の必要性は、慢性疾患の増加、ヘルスケアインフラの拡大、世界人口の高齢化により、効果的な医薬品への需要が増加していることが背景にあります。その用途は、がん、循環器、中枢神経系疾患、感染症など多岐にわたる。最終用途の範囲には、製薬会社やバイオテクノロジー企業、製造受託機関（CMO）が主に含まれます。市場成長は、ジェネリック医薬品の急増、ブロックバスター医薬品の特許切れ、創薬技術の進歩などの影響を大きく受けています。研究開発活動の活発化と有利な規制の枠組みが、さらに潜在的なビジネスチャンスをもたらしています。企業は個別化医療に注力し、バイオシミラーのポートフォリオを拡大することで、こうした機会を活用することができます。しかし、厳しい規制遵守、高額な投資コスト、複雑な製造工程などの制約が課題となっています。競合情勢もまた、技術革新と市場シェアの獲得に邁進する多数のプレイヤーの存在によって激化しています。成長の可能性をもたらすイノベーションと研究の分野には、連続製造プロセス、環境に優しい合成ルート、先進ドラッグデリバリーシステムなどがあります。さらに、薬剤設計と開発におけるAIと機械学習の統合は、事業拡大の新たな道を提示します。市場の性質に関する競合考察では、技術の進歩と進化する規制政策に後押しされた市場のダイナミックで競合的な性質が強調されています。企業は、戦略的提携と継続的イノベーションを優先し、優位に立つべきです。主要な課題に取り組み、持続可能な慣行に焦点を当てることで、企業は市場をうまく乗り切り、成長を達成することができます。

市場力学：急速に進化する低分子原薬市場の主要市場インサイトを公開

低分子原薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の高齢者人口の増加に伴う慢性疾患の蔓延
  • 世界のジェネリック医薬品需要の高まり
• 市場抑制要因
  • 低分子原薬に関連する高コスト
• 市場機会
  • 創薬および開発における継続的な進歩
  • 併用療法のためのバイオ製薬企業との提携
• 市場の課題
  • 医薬品開発に対する厳しい規制要件

ポーターのファイブフォース：低分子原薬市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：低分子原薬市場における外部からの影響の把握

外部マクロ環境要因は、低分子原薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析低分子原薬市場における競合情勢の把握

低分子原薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス低分子原薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、低分子原薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨低分子原薬市場における成功への道筋を描く

低分子原薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加と世界的に高齢化が進む
    • 世界中でジェネリック医薬品の需要が増加
  • 抑制要因
    • 低分子原薬に関連する高コスト
  • 機会
    • 医薬品の発見と開発における継続的な進歩
    • 併用療法に関するバイオ医薬品企業との提携
  • 課題
    • 医薬品開発に対する厳格な規制要件
• 市場セグメンテーション分析
  • タイプ：副作用が少ないため、生物学的ベースの低分子原薬への傾向が高まっている
  • 生産：品質基準を確保するために社内での製造を増やす
  • アプリケーション：腫瘍学の継続的な進歩により、低分子原薬の利用が強化されます。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 低分子原薬市場：タイプ別

• 生物学的
• 合成

第7章 低分子原薬市場制作者

• 契約製造
• 社内製造

第8章 低分子原薬市場：用途別

• 心臓血管
• 糖尿病
• 免疫疾患
• 腫瘍学

第9章 南北アメリカの低分子原薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の低分子原薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの低分子原薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ロンザ、新薬候補のルート探索を簡素化するAI搭載サービスを開始
  • 無錫STA、APIリアクターの容量を拡大し、ペプチド製造能力を3倍に増強して世界の需要に対応
  • グラニュールズ、新たなグリーン小分子API製造施設に2億5,000万米ドルを投資
  • SSTコーポレーションとViwit Pharmaceuticalsが戦略的提携を確立
  • APIはウォータールー大学の科学者と提携し、コロナウイルスに対する広範囲の低分子治療薬を開発中
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Agilent Technologies, Inc.
• Alacrita Holdings Limited
• Albemarle Corporation
• Aspen Group
• Astrazeneca PLC
• Aurobindo Pharma Limited
• Bachem Holding AG
• Bio-Rad Laboratories, Inc.
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb
• Cambrex Corporation by Permira funds
• Carlyle Group
• Charles River Laboratories International, Inc.
• Deciphera Pharmaceuticals, Inc.
• Dr. Reddy's Laboratories Ltd.
• F. Hoffmann-La Roche Ltd,
• Gilead Sciences, Inc
• GlaxoSmithKline PLC
• Koninklijke DSM N.V.
• Lonza Group AG
• Merck KGaA
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
• FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
• TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

The Small-Molecule APIs Market was valued at USD 184.32 billion in 2023, expected to reach USD 197.35 billion in 2024, and is projected to grow at a CAGR of 7.26%, to USD 301.19 billion by 2030.

The scope of the Small-Molecule APIs market encompasses a wide range of pharmaceutical ingredients that are crucial for drug formulation. These molecules are small organic compounds that aid in the diagnosis, treatment, and prevention of diseases. The necessity for small-molecule APIs is driven by the increasing demand for effective medications due to rising chronic diseases, expanding healthcare infrastructure, and an aging global population. Their applications are vast, including oncology, cardiovascular, central nervous system disorders, and infectious diseases, among others. The end-use scope primarily covers pharmaceutical and biotechnology companies, as well as contract manufacturing organizations (CMOs). Market growth is influenced significantly by the surge in generic drug production, patent expirations of blockbuster drugs, and advancements in drug discovery technologies. Increased research and development activities and favorable regulatory frameworks further provide potential opportunities. Companies can capitalize on these opportunities by focusing on personalized medicine and expanding their biosimilars portfolio. However, limitations such as stringent regulatory compliance, high investment costs, and complex manufacturing processes present challenges. The competitive landscape is also intensified by the presence of numerous players striving for innovation and market share. Areas of innovation and research that offer growth potential include continuous manufacturing processes, eco-friendly synthesis routes, and advanced drug delivery systems. Additionally, integration of AI and machine learning in drug design and development presents new avenues for business expansion. Insights into the nature of the market highlight its dynamic and competitive nature, driven by technological advancements and evolving regulatory policies. Companies should prioritize strategic collaborations and continuous innovation to stay ahead. By addressing key challenges and focusing on sustainable practices, businesses can successfully navigate the market and achieve growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Small-Molecule APIs Market

The Small-Molecule APIs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic diseases coupled with increasing geriatric population globally
  • Rising demand for generic drugs worldwide
• Market Restraints
  • High cost associated with small-molecule APIs
• Market Opportunities
  • Ongoing advancements in drug discovery and development
  • Collaborations with bio-pharmaceutical companies for combination therapies
• Market Challenges
  • Stringent regulatory requirements for drug development

Porter's Five Forces: A Strategic Tool for Navigating the Small-Molecule APIs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Small-Molecule APIs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Small-Molecule APIs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Small-Molecule APIs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Small-Molecule APIs Market

A detailed market share analysis in the Small-Molecule APIs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Small-Molecule APIs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Small-Molecule APIs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Small-Molecule APIs Market

A strategic analysis of the Small-Molecule APIs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Biological and Synthetic.
• Based on Production, market is studied across Contract Manufacturing and In-House Manufacturing.
• Based on Application, market is studied across Cardiovascular, Diabetes, Immunological Disorders, and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
    • 5.1.1.2. Rising demand for generic drugs worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with small-molecule APIs
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in drug discovery and development
    • 5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for drug development
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
  • 5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
  • 5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Small-Molecule APIs Market, by Type

• 6.1. Introduction
• 6.2. Biological
• 6.3. Synthetic

7. Small-Molecule APIs Market, by Production

• 7.1. Introduction
• 7.2. Contract Manufacturing
• 7.3. In-House Manufacturing

8. Small-Molecule APIs Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular
• 8.3. Diabetes
• 8.4. Immunological Disorders
• 8.5. Oncology

9. Americas Small-Molecule APIs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Small-Molecule APIs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Small-Molecule APIs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Lonza Launches AI-Powered Service to Simplify Route Scouting for New Drug Candidates
  • 12.3.2. WuXi STA Expands API Reactor Volume and Triples Peptide Manufacturing Capacity to Meet Global Demand
  • 12.3.3. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
  • 12.3.4. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
  • 12.3.5. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Agilent Technologies, Inc.
• 3. Alacrita Holdings Limited
• 4. Albemarle Corporation
• 5. Aspen Group
• 6. Astrazeneca PLC
• 7. Aurobindo Pharma Limited
• 8. Bachem Holding AG
• 9. Bio-Rad Laboratories, Inc.
• 10. Boehringer Ingelheim GmbH
• 11. Bristol-Myers Squibb
• 12. Cambrex Corporation by Permira funds
• 13. Carlyle Group
• 14. Charles River Laboratories International, Inc.
• 15. Deciphera Pharmaceuticals, Inc.
• 16. Dr. Reddy's Laboratories Ltd.
• 17. F. Hoffmann-La Roche Ltd,
• 18. Gilead Sciences, Inc
• 19. GlaxoSmithKline PLC
• 20. Koninklijke DSM N.V.
• 21. Lonza Group AG
• 22. Merck KGaA
• 23. Pfizer, Inc.
• 24. Teva Pharmaceutical Industries Ltd.